6533b86dfe1ef96bd12c9d4c
RESEARCH PRODUCT
An international, phase 3, switchover study of reveglucosidase alfa (BMN 701) in subjects with late-onset Pompe disease
W. DummerEugen MengelPeter YoungDerralynn HughesTahseen MozaffarTarekegn HiwotF. EyskensBarry J. ByrneMark RobertsBenedikt SchoserJohn T. KisselJeffrey StatlandK. SivakumarC. HeusnerAlan Pestronksubject
Pediatricsmedicine.medical_specialtyNeurologybusiness.industryPediatrics Perinatology and Child HealthSwitchoverMedicineLate onsetNeurology (clinical)DiseasebusinessGenetics (clinical)Surgeryyear | journal | country | edition | language |
---|---|---|---|---|
2015-10-01 | Neuromuscular Disorders |